Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 26, 2009 - Issue 8
Submit an article Journal homepage
213
Views
13
CrossRef citations to date
0
Altmetric
Invited Commentary

HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution

Abraham FongSeattle Children's Hospital and University of Washington, Department of Pediatrics, Seattle, Washington, USACorrespondence[email protected]
, MD, PhD &
Julie R. ParkSeattle Children's Hospital and University of Washington, Department of Pediatrics, Seattle, Washington, USA
, MD
Pages 539-548 | Accepted 16 Jun 2009, Published online: 02 Dec 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rani E George, Lisa Diller & Mark L Bernstein. (2010) Pharmacotherapy of neuroblastoma. Expert Opinion on Pharmacotherapy 11:9, pages 1467-1478.
Read now

Articles from other publishers (12)

Fadime Çetin, Sifa Kosba, Hüseyin Abdik & Zeynep Busra Bolat. (2023) Synergistic anti-proliferative and apoptotic effect of NVP-BEZ235 and curcumin on human SH-SY5Y neuroblastoma cells. Medical Oncology 41:1.
Crossref
Taranom Mobasheri, Elham Rayzan, Mahsima Shabani, Mina Hosseini, Ghanbar Mahmoodi Chalbatani & Nima Rezaei. (2020) Neuroblastoma‐targeted nanoparticles and novel nanotechnology‐based treatment methods. Journal of Cellular Physiology 236:3, pages 1751-1775.
Crossref
Gabriella Casinelli, Jeff LaRosa, Manika Sharma, Edward Cherok, Swati Banerjee, Maria Branca, Lia Edmunds, Yudong Wang, Sunder Sims-Lucas, Luke Churley, Samantha Kelly, Ming Sun, Donna Stolz & J Anthony Graves. (2016) N-Myc overexpression increases cisplatin resistance in neuroblastoma via deregulation of mitochondrial dynamics. Cell Death Discovery 2:1.
Crossref
Li-Di Zhang, Zhen Liu, Hua Liu, Dong-Mei Ran, Jia-Hui Guo, Bin Jiang, Ying-Li Wu & Feng-Hou Gao. (2016) Oridonin enhances the anticancer activity of NVP-BEZ235 against neuroblastoma cells in vitro and in vivo through autophagy. International Journal of Oncology 49:2, pages 657-665.
Crossref
Ewa Izycka-Swieszewska & Agnieszka Wozniak. 2012. Pediatric Cancer, Volume 2. Pediatric Cancer, Volume 2 89 98 .
Carla S Verissimo, Jan J Molenaar, Carlos P Fitzsimons & Erno Vreugdenhil. (2011) Neuroblastoma therapy: what is in the pipeline?. Endocrine-Related Cancer 18:6, pages R213-R231.
Crossref
Anna Frenzel, Hanna Zirath, Marina Vita, Ami Albihn & Marie Arsenian Henriksson. (2011) Identification of Cytotoxic Drugs That Selectively Target Tumor Cells with MYC Overexpression. PLoS ONE 6:11, pages e27988.
Crossref
Jyotsana Singhal, Sushma Yadav, Lokesh Dalasanur Nagaprashantha, Rit Vatsyayan, Sharad S. Singhal & Sanjay Awasthi. (2011) Targeting p53-Null Neuroblastomas through RLIP76. Cancer Prevention Research 4:6, pages 879-889.
Crossref
Ewa Izycka-Swieszewska, Agnieszka Wozniak, Elzbieta Drozynska, Jacek Kot, Wieslawa Grajkowska, Teresa Klepacka, Danuta Perek, Sylwia Koltan, Ewa Bien & Janusz Limon. (2011) Expression and significance of HER family receptors in neuroblastic tumors. Clinical & Experimental Metastasis 28:3, pages 271-282.
Crossref
Brunella Del Re, Pamela Marcantonio, Miriam Capri & Gianfranco Giorgi. (2010) Evaluation of LINE-1 mobility in neuroblastoma cells by in vitro retrotransposition reporter assay: FACS analysis can detect only the tip of the iceberg of the inserted L1 elements. Experimental Cell Research 316:20, pages 3358-3367.
Crossref
Ewa Izycka-Swieszewska, Agnieszka Wozniak, Jacek Kot, Wieslawa Grajkowska, Anna Balcerska, Danuta Perek, Bozena Dembowska-Baginska, Teresa Klepacka & Elzbieta Drozynska. (2010) Prognostic significance of HER2 expression in neuroblastic tumors. Modern Pathology 23:9, pages 1261-1268.
Crossref
M. Filippou, A. Vassiliou & G. Sakellaris. (2010) Neuroblastoma in childhood. Hellenic Journal of Surgery 82:3, pages 184-191.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.